Monsanto Q2 Earnings Rise on Higher Corn Sales
Monsanto Company (MON) reported improved results for the second quarter of fiscal 2014 (ended Feb 28, 2014), with year-over-year improvement in revenues and earnings. The company recorded earnings per share from continuing operations of $3.15, beating the Zacks Consensus Estimate of $3.09 by 1.9%. Reported earnings were also more than $2.74 earned a year ago.
Revenues: Second-quarter revenues of $5,832.0 million were marginally below the Zacks Consensus Estimate of $5,855.0 million. However, revenues increased 6.6% year over year.
On a segmental basis, revenues from Seeds and Genomics increased 7.0% year over year to $4.6 billion. The increase was the result of improvement in the corn and soy businesses. Revenues from Agricultural Productivity increased 5.2% year over year to $1.2 billion buoyed by favorable demand.
Cost & Margins: Monsanto’s gross profit margin was 59% compared with 56% recorded in the year-earlier quarter. Operating expenses were recorded at $1,029.0 million, higher than $958.0 million in the year-ago quarter.
In the reported quarter, selling, general and administrative, and research and development expenses, as a percentage of net sales, were recorded at 11.0% and 7.0%, respectively.
Balance Sheet/Cash Flow: Exiting fiscal second-quarter 2014, Monsanto’s cash and cash equivalents were approximately $3.8 billion compared with $4.5 billion at the end of fiscal first-quarter 2014. Long-term debt was roughly flat with the prior quarter at $3.1 billion.
In the six months ending Feb 2014, cash flow from operations was $1.8 billion, roughly flat year over year. Total capital spending was roughly $471.0 million against $261.0 million spent in the half year ended Feb 2013.
In the reported quarter, the company spent roughly $203.0 million on share repurchase.
Outlook: Based on the improved performance, management reaffirmed its expectations for fiscal 2014. Earnings per share are expected in the range of $5.00 to $5.20. On an as-reported basis, the company expects to earn $5.02 to $5.22 per share. However, the company also expects to experience 15 to 20 cents headwinds from foreign currency impacts.
Management also reaffirmed free cash flow in the range of $600.0 to $800.0 million. Cash flow from operating activities is projected in the range of $2.9 to $3.3 billion. Moreover, cash required for investing activities are expected within $2.3 to $2.5 billion.
Other Stocks to Consider
Monsanto currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the industry include CVR Partners, LP (UAN), The Scotts Miracle-Gro Company (SMG) and International Flavors & Fragrances Inc. (IFF). All these stocks have a Zacks Rank #2 (Buy).
Read the Full Research Report on MON
Read the Full Research Report on UAN
Read the Full Research Report on IFF
Read the Full Research Report on SMG
Zacks Investment Research
